13 completed, 5 recruiting. 13 Phase 2, 6 Phase 3, 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 10, Recruiting 3 |
| Phase 3 | 6 | Completed 5, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
Follow Mostafa Bahaa: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical and Radiographic Evaluation of Using Regular Versus Narrow Diameter Dental Implantto Support Mandibular Complete Over Denture Implant - DENT IMPLANTS | Phase 2 | Recruiting | Mostafa Bahaa | 12 | 2026-08-25 | 2026-10-02 |
| Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients Febuxostat Tablets, Metformin - Gout | Phase 2 | Completed | Mostafa Bahaa | 60 | 2025-05-30 | 2026-09-17 |
| Metformin in Safety and Efficacy in Gouty Patients placebo, Metformin - Gout | Phase 2 | Recruiting | Mostafa Bahaa | 70 | 2025-04-20 | 2026-09-30 |
| Comparative Study of Blood Loss in Total Laparoscopic Hysterectomy by Ligation the Uterine Arteries in Different Techniques. BTLH with bilateral uterine artery ligation from its origin, Conventional TLH - Gynecologic Disease | Not applicable | Completed | Mostafa Bahaa | 60 | 2025-03-12 | 2026-05-04 |
| Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes Insulin, Semaglutide, Empagliflozin - Diabetes | Phase 2 | Completed | Mostafa Bahaa | 114 | 2025-01-20 | 2026-09-02 |
| Doxycycline in Type II Diabetes Sitagliptin 100mg, Doxycyclin - Diabetes Mellitus, Type 2 | Phase 1 / Phase 2 | Completed | Mostafa Bahaa | 60 | 2024-03-30 | 2026-09-17 |
| Effect of Vitamin D Injection on Hypertrophic Scars and Keloids Cholecalciferol - Dermatologic Disease | Phase 1 / Phase 2 | Completed | Mostafa Bahaa | 35 | 2024-02-27 | 2025-04-08 |
| Paroxetine Safety and Efficacy in Rheumatoid Arthritis Methotrexate, Paroxetine - Rheumatoid Arthritis | Phase 3 | Completed | Mostafa Bahaa | 100 | 2024-01-31 | 2026-05-04 |
| Metformin Safety and Efficacy in Osteoarthritis. Celecoxib 200mg, Metformin - Osteo Arthritis Knee | Phase 3 | Recruiting | Mostafa Bahaa | 70 | 2024-01-30 | 2026-03-13 |
| Correlation Between Depression Scores and Serum NF-ĸB/NLRP3 Axis, Biotinidase, and HMGB After Treatment With Isotretinoin in Patients With Acne Vulgaris ISOtretinoin 20 MG - Acne Vulgaris | Phase 3 | Completed | Mostafa Bahaa | 40 | 2024-01-30 | 2025-03-04 |
| Minocyclin in Ulcerative Colitis as Added on Therapy Mesalazine, Minocycline - Inflammatory Bowel Diseases | Phase 2 | Completed | Mostafa Bahaa | 46 | 2024-01-22 | 2025-11-18 |
| Montelukast in Parkinson Disease levodopa-carbidopa, Montelukast - Parkinson Disease | Phase 2 / Phase 3 | Completed | Mostafa Bahaa | 60 | 2023-11-05 | 2026-10-02 |
| Dapagliflozin in Patients With Ulcerative Colitis Mesalamine, Dapagliflozin 10mg Tab - Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Completed | Mostafa Bahaa | 60 | 2023-08-20 | 2026-09-21 |
| Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis Mesalamine, Nifuroxazide - Inflammatory Bowel Diseases | Phase 2 / Phase 3 | Completed | Mostafa Bahaa | 50 | 2023-08-20 | 2026-10-13 |
| Role of Pentoxifylline and Celecoxib in Parkinsonism carbidopa-levodopa, Pentoxifylline 400 MG, Celecoxib 200mg - Parkinson Disease | Phase 2 | Completed | Mostafa Bahaa | 80 | 2023-08-07 | 2025-08-12 |
| Investigating the Pathophysiological Nature of Homosexuality Subjective Scale of Stigma and Discrimination (SISD). - Psychiatric Disorder | Recruiting | Mostafa Bahaa | 500 | 2023-07-20 | 2026-03-16 | |
| Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease Valsartan 80 mg, Empagliflozin 10 MG, Levocetirizine - Diabetic Nephropathies | Phase 2 | Completed | Mostafa Bahaa | 60 | 2022-12-20 | 2026-03-31 |
| Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy Phenytoin, Pentoxifylline 400 MG, Celecoxib 200mg - Epilepsy | Phase 2 | Recruiting | Mostafa Bahaa | 90 | 2022-12-20 | 2024-07-18 |
Inflammatory Bowel Diseases (3) · Gout (2) · Parkinson Disease (2) · Acne Vulgaris (1) · Arthritis, Rheumatoid (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Nephropathies (1) · Epilepsy (1) · Genital Diseases, Female (1) · Mental Disorders (1) · Skin Diseases (1)
Celecoxib (3) · Mesalamine (3) · Metformin (3) · Pentoxifylline (2) · carbidopa, levodopa drug combination (2) · empagliflozin (2) · Cholecalciferol (1) · Doxycycline (1) · Drug Implants (1) · Febuxostat (1) · Insulin (1) · Isotretinoin (1) · Methotrexate (1) · Minocycline (1) · Paroxetine (1)
Egypt (18)
PMID 39340691, PMID 40135774, PMID 40253769, PMID 40620467, PMID 40739381, PMID 40946347, PMID 41128897, PMID 41488752, PMID 42271067